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a  b  s  t  r  a  c  t
The  small  circular  mitochondrial  genome  in  mammalian  cells  is  replicated  by  a dedicated  replisome,
defects  in  which  can  cause  mitochondrial  disease  in  humans.  A fundamental  step  in mitochondrial  DNA
(mtDNA)  replication  and  maintenance  is  the removal  of  the  RNA  primers  needed  for  replication  initiation.
The  nucleases  RNase  H1,  FEN1,  DNA2,  and  MGME1  have  been  implicated  in this  process.  Here  we  review
the  role  of these  nucleases  in  the  light  of  primer  removal  pathways  in mitochondria,  highlight  associationseywords:
tDNA
NA primer
Nase H1
EN1
NA2
with  disease,  as  well  as consider  the implications  for mtDNA  replication  initiation.
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Fig. 1. Map  of the human mitochondrial genome.
The major non-coding regions are the NCR (non-coding region), and OriL (origin
of  replication for the light strand). The outer and inner circles are the heavy (H)
and  light (L) strands, respectively. The NCR (enlargement shown above genome;
nucleotide positions indicated in grey) contains the H- and L-strand promoters
(HSP, LSP), three conserved sequence boxes (CSB1-3), the H-strand origin of repli-
cation (OriH) and the termination-associated sequence (TAS). Replication initiated
at  OriH often preterminates and the nascent strand (7S DNA) remains bound to
the  template creating a displacement loop (D-loop). Gene color coding: complex
III  cytochrome b (Cyt b)—pink; complex I NADH dehydrogenase (ND) genes—blue;
complex IV cytochrome c oxidase (COX) genes—green; complex V ATP synthaseReferences  . . .  . . .  . .  . . . . .  . . . . . . .  . . .  . . .  .  . . .  .  . . .  . . . . . . . . . . . . . . .  . . .  . .  . .  .  . . .
. Introduction
Mitochondria are vital in providing cellular energy in the form
f ATP through the oxidative phosphorylation pathway (OXPHOS).
he OXPHOS system depends on expression of the mitochondrial
enome that encodes key subunits of the respiratory chain. As a
onsequence, defects in mtDNA maintenance or sequence can lead
o mitochondrial disorders comprising a heterogeneous range of
linical symptoms and syndromes [1–3]. Some patients carry muta-
ions in components of the mitochondrial replication/transcription
ystem, which can lead to mtDNA deletions and depletions [4,5].
tDNA mutations are also implicated in normal ageing, neurode-
enerative diseases and cancer [1,6].
Initiation and elongation of mammalian mtDNA replication is
elatively well understood (recent reviews include [4,7,8]). Repli-
ation is initiated at two strand-speciﬁc origins and requires the
riming activity of the mitochondrial RNA polymerase (POLRMT).
ach mtDNA strand is then replicated continuously by POL, the
itochondrial DNA polymerase.
Termination of mtDNA replication is comparably less well stud-
ed. A key step in genome maintenance that is often overlooked is
he removal of RNA replication primers and ligation of the nascent
NA ends. Without this, gaps and nicks will form in the DNA result-
ng in genome instability. While primer removal in nuclear DNA has
een thoroughly studied for decades, few studies have addressed
his in the mitochondrial genome. Here we review what nucleases
nd pathways are implicated in the processing of primers during
ammalian mtDNA replication. We  relate this to disease, draw
omparisons with Okazaki fragment maturation, and discuss the
mplications for mtDNA replication initiation.
. The mitochondrial genome
Mitochondrial DNA in humans is an approximately 16.6 kb long
ouble-stranded circular molecule (Fig. 1). The two  strands can be
eparated on denaturing cesium chloride gradients and are there-
ore referred to as the heavy strand (H-strand) and the light strand
L-strand). The mitochondrial genome is highly compact, contain-
ng no introns and little non-coding DNA. It codes for 13 subunits of
he OXPHOS complexes, as well as 2 ribosomal RNAs and 22 transfer
NAs that are required for translation of the OXPHOS subunits. All
ther proteins (∼99%), including those required for mtDNA repli-
ation and transcription, are encoded by nuclear genes and are
mported from the cytoplasm.
Somatic cells contain between 1000–10,000 copies of mtDNA,
ith 2–10 copies per mitochondrion. MtDNA is packaged into
NA–protein complexes called nucleoids of which the major pro-
ein component is mitochondrial transcription factor A (TFAM)
9–12]. In addition to replication and transcription proteins,
ucleoids also contain known components of the inner membrane,
uggesting that mtDNA may  be membrane associated [13].
MtDNA contains two regions of non-coding DNA: a ∼1 kb
equence known as the non-coding region (NCR; Fig. 1 top panel),
nd a distant ∼30 nt sequence containing the origin of replication
or the L-strand (OriL). The NCR contains one transcription pro-
oter for each strand (light strand promoter—LSP; heavy strand
romoter—HSP). It also contains the origin of replication for the H-
trand (OriH), classically annotated at position 191 nt, though less
ominant origins have been reported nearby (reviewed in [14]).(ATPase) genes—yellow; ribosomal RNA (rRNA)—orange; transfer RNA genes—black
boxes.
Also present in the NCR are three conserved sequence blocks (CSB1-
3) between LSP and OriH.
A region between OriH and the termination-associated
sequence (TAS) at the end of the NCR can form a displacement-loop
(D-loop), called such because it forms a triple-stranded structure
created by prematurely terminated replication from OriH. The pre-
terminated nascent H-strand, called 7S DNA (∼650 nt), remains
annealed to the template strand, though its function remains
largely unknown [15].
30 J.P. Uhler, M. Falkenberg / DNA Repair 34 (2015) 28–38
Fig. 2. The mtDNA replication fork.
TWINKLE helicase (blue) unwinds the dsDNA in a 5′–3′ direction. POLRMT (orange)
is  shown synthesizing the RNA primer (red) at OriL. The DNA polymerase POL
(yellow) is made of one A subunit and two B subunits. Tetrameric mtSSB (green)
stabilizes single stranded DNA. Template DNA—black; nascent DNA—blue.
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(A) In the strand displacement replication mode, replication initiates from an RNA
primer (red) at OriH. DNA synthesis (black arrows) of the H-strand proceeds uni-
directionally, displacing the parental H-strand. When OriL is exposed, L-strand
synthesis is initiated and proceeds in the opposite direction. (B) Schematic of OriH
and  OriL priming. Upper panel: an RNA primer (red wavy line) is transcribed from
LSP. RNA–DNA transitions (dashed red/black line) occur near the 3′-end of CSB2.
5′-end processing of the DNA (black dashed line) generates a mature 5′-end of the
nascent DNA (solid black) at OriH. Nucleotide positions are indicated in grey. Lower
panel: an RNA primer (red wavy line) is transcribed from a stem-loop formed in the
This cycle is repeated in a process called idling and is essential
for maintaining a ligatable nick [31]. Nucleases therefore have. Overview of mitochondrial primer formation and DNA
eplication
The core factors required for mitochondrial primer formation
nd DNA replication are distinct from those in the nucleus (Fig. 2).
OLRMT, a single subunit RNA polymerase, is responsible for all
itochondrial transcription including primer formation. POL, the
nly known replicative DNA polymerase in mitochondria, com-
rises the catalytic A subunit and two accessory B subunits. In
ddition to its polymerase activity, POLA also harbors 3′–5′ exonu-
lease activity and lyase activity [16,17]. The duplex DNA at the
eplication fork is unwound by the hexameric 5′–3′ TWINKLE heli-
ase, while mitochondrial single stranded DNA binding protein
mtSSB) protects the single stranded DNA created in its wake.
ost probably because mitochondria originated from an alpha-
roteobacterium that invaded a primordial eukaryotic cell, several
f the mtDNA replication/transcription factors bear similarity to
acteriophage or bacterial proteins, including POLA, POLRMT,
WINKLE, and mtSSB [14].
Three models have been proposed to explain how mtDNA is
rimed and replicated (reviewed in [7,14]). According to the strand
isplacement model proposed over 30 years ago, replication is ini-
iated at OriH (Fig. 3A). DNA synthesis is primed by transcription
rom LSP located ∼200 nt upstream of OriH (Fig. 3B). LSP transcrip-
ion can either produce a near full-length polycistronic transcript
or gene expression, or it can be pre-terminated near CSB2 and serve
s the RNA primer for replication initiation at OriH [18–20]. The
echanism regulating the switch between genome transcription
nd primer formation involves a G-quadruplex forming sequence
t CSB2, located ∼100 nt downstream of LSP [21,22].
Once initiated, H-strand synthesis proceeds unidirectionally
nd displaces the parental H-strand (Fig. 3A). When the replication
achinery passes the second origin, OriL, it becomes single-
tranded and forms a stem-loop structure from which POLRMT
nitiates primer synthesis (∼20–30 nt; Fig. 3B). L-strand DNA syn-
hesis initiates from OriL and proceeds in a continuous mode
n the opposite direction to H-strand synthesis. This means that
oth H-strand and L-strand DNA synthesis only require a single
riming event each, after which the strands are continuously syn-
hesized until coming full circle. L-strand replication may in some
ells/tissues also be primed from cryptic L-strand sites [23]. Sup-
ort for the OriH and OriL origins includes the mapping of free
′-ends to these sites [24], reconstitution of replication initiation
t OriL in vitro [25,26], and the abnormal occurrence of an 11 kb
inear replication product, the ends of which map  to these origins
27,28].single stranded H-strand template. RNA–DNA transitions (dashed red/black line);
nascent L-strand (solid black). Nucleotide positions are indicated in grey.
4. Overview of primer processing
Due to the circular nature of mtDNA, replication termination
most likely occurs at or very close to the origins OriH and OriL.
What happens when POL completes DNA synthesis and reaches
the RNA primers is not clear, but in principle, the primers must
at some point be replaced with DNA. The factors and pathways
required for primer processing are beginning to emerge.
4.1. Lessons from primer processing in the nucleus
Much insight can be gained from studies on primer removal
during Okazaki fragment maturation of lagging-strand replication
in the nucleus (recent reviews include [29,30]). Notably, primer
removal pathways here all involve displacement of the primer by
the replicating DNA polymerase (Pol) when it reaches the 5′-
end of the RNA primer of the previously formed Okazaki fragment
(Fig. 4A). In the absence of a helicase, Pol can synthesize a few
nucleotides into the duplex region by strand displacement synthe-
sis, creating a short 5′-primer ﬂap. This ﬂap can then be cleaved
away by nucleases, creating a ligatable 5′-DNA end through which
the Okazaki fragments can be ligated.
This mechanism of primer ﬂap formation and cleavage only
favors ligation if Pol strand displacement is limited to a few
nucleotides. Otherwise, ﬂaps can regenerate after cleavage, or
uncleavable secondary structures may  form in long ﬂaps. Strand
displacement is kept low by the 3′–5′ exonuclease activity of Pol.
Here, the nucleotides added during strand displacement can be sub-
sequently 3′–5′ degraded until Pol returns to the nick position.repeated opportunities to cleave the transiently formed ﬂaps. Once
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Fig. 4. Primer removal pathways in the nucleus.
(A) Primer removal involves strand displacement synthesis and cleavage of primer ﬂap intermediates. Replicating DNA polymerase (yellow) reaches the 5′-end of a down-
stream  RNA primer (red wavy line). The polymerase synthesizes a few nucleotides beyond the 5′-end, creating a single stranded ﬂap that is cleaved away by nucleases
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escissors). (B) Models of nuclease pathways during Okazaki fragment maturation.
isplacement synthesis (black arrow) creates a ﬂap that is cut by FEN1. FEN1 pathw
NA2/FEN1 pathway: a long ﬂap is formed and is covered by RPA (circles). DNA2 cl
he RNA primer is completely removed and replaced with DNA,
igase seals the nick.
What are the nucleases? Three nucleases—ribonuclease H2
RNase H2), ﬂap structure-speciﬁc endonuclease 1 (FEN1), and DNA
eplication helicase/nuclease 2 (DNA2)—are proposed to operate
hrough three main pathways (Fig. 4B). In the RNase H2/FEN1 path-
ay, RNase H2 ﬁrst degrades most of the annealed RNA primer. The
nal RNase H2 resistant ribonucleotides are then displaced into a
ap by Pol and cleaved away by the ﬂap endonuclease FEN1. In
he FEN1 pathway (also called short ﬂap pathway), Pol strand dis-
lacement synthesis generates a 1–2 nt primer ﬂap which is then
leaved by FEN1 [31]. This process is reiterated through nick trans-
ation until the RNA is completely removed. In the DNA2/FEN1
or long ﬂap) pathway, single stranded DNA binding protein RPA
replication protein A) binds to a long ﬂap that has escaped FEN1
leavage due to helicase activity for example. RPA-bound DNA is
nhibitory to FEN1, necessitating the activity of a second nuclease,
NA2. Cleavage by DNA2 leaves behind a short ﬂap that FEN1 can
leave away.
.2. Mitochondrial primer processing
Not all DNA polymerases possess strand displacement activ-
ty. Interestingly, the mitochondrial DNA polymerase POL, like
ol, possesses limited strand displacement activity [32,33], sug-
esting that primer ﬂap intermediates are likely to be involved in
rimer removal in mitochondria too. POL has also been shown
o idle at the 5′-end of a primer [33] and as for Pol, the intrin-
ic 3′–5′ exonuclease activity of POL is essential for limiting its
trand displacement activity and promoting ligation [34]. Thus,
pon reaching the 5′-end of a primer, the polymerase and 3′–5′
xonuclease activities of POL are delicately balanced to favor RNA
rimer removal and DNA ligation. This balance can become dis-
upted by mutations in the exonuclease domain, some of which
re associated with human mitochondrial disease [34].
The discovery of nucleases within mitochondria, deﬁciencies
n which are associated with mtDNA defects, further implies that
rimer ﬂap pathways operate here. In the past ten years in fact, all
f the primary factors implicated in Okazaki fragment maturation,
EN1, DNA2, and RNase H2, have been suggested to have mitochon-
rial counterparts. We  will discuss the possible roles of these, as
ell as the recently identiﬁed mitochondrial genome maintenance
xonuclease 1 (MGME1) protein, in mtDNA maintenance.e H2/FEN1pathway: RNase H2 degrades most of the annealed RNA before strand
and displacement synthesis creates reiterative short ﬂaps that are cleaved by FEN1.
 the ﬂap, leaving a short RPA-free ﬂap that is cut by FEN1.
4.3. Identifying mitochondrial factors
To qualify as a credible primer processing factor, several lines
of evidence should be considered. It must ﬁrstly be shown that the
candidate protein has mitochondrial localization. Well-established
cytological and biochemical assays are routinely used for this
purpose. In addition, the puriﬁed factor must possess enzymatic
activity that can process primer substrates in vitro, ideally with the
mtDNA replication system. Finally, loss of function of a primer pro-
cessing factor should cause mtDNA defects in vivo. How to predict,
detect and interpret defects that reﬂect primer removal deﬁciency
is challenging though.
One can expect that incomplete primer removal will lead to
ligation defects, since the mitochondrial DNA ligase (Lig3) discrim-
inates against RNA [35]. Cellular depletion of Lig3 causes increased
mtDNA nicks and single stranded gaps, as well as reduced mtDNA
levels [36,37]. Lig3 deletion in mice causes embryonic lethality
with development arresting at embryonic day E8.5 [38], while dele-
tion in the nervous system leads to loss of mtDNA and premature
death [39]. Furthermore, recent data suggest that the linear 11 kb
mtDNA fragment that is found in the exonuclease-deﬁcient POL
mutator mouse, is caused by ligation problems of the nascent DNA
strand [34]. Upon completion of H-strand replication, exonuclease-
deﬁcient POL displaces the downstream 5′-end of the nascent
strand excessively and creates a persistent unligatable ﬂap at OriH
(Fig. 5, left panels). The resulting nick leads to a double stranded
break during the next round of L-strand replication initiated from
OriL (Fig. 5, right panels). Based on these ﬁndings, improper primer
removal may  cause similar defects in mtDNA.
5. Nucleases implicated in mitochondrial primer
processing
5.1. RNase H1
RNase H endonucleases have long been implicated in primer
removal during nuclear lagging-strand DNA replication because
they hydrolyze the RNA strand of RNA/DNA heteroduplexes and
their expression correlates with DNA synthesis [40]. In mammals
there are two classes of RNase H protein, RNase H1 and H2, (called
RNase HII and HI respectively until the early 00s), which are ubiq-
uitously expressed in cells and tissues. Both are present in the
nucleus, but only RNase H1 localizes to mitochondria [41–46]. The
32 J.P. Uhler, M. Falkenberg / DNA
Nicked H-strand
OriH
5´-flap
Nick
Nick
OriL
dsDNA break
L-strand template Nicked H-strand template
11 kb linear fragment
next round
Fig. 5. Model on how ligation failure at OriH generates an 11 kb linear fragment.
Replication of the nascent H-strand (green dashed arrow) initiates from OriH (top
left  panel). When POL reaches the 5′-end of the nascent strand, a transient 5′-ﬂap
is  formed. A persistent ﬂap (due to exonuclease-deﬁcient POL strand displacement
or  nuclease deﬁciency) will lead to ligation failure, resulting in a daughter molecule
with a nick on the H-strand near OriH (bottom left panel). In the next replication
round, replication initiated from the intact L-strand template will lead to regener-
ation of the nicked molecule (left panels), while replication initiated from OriL on
the nicked H-strand template will generate an 11 kb linear fragment (right panels).
Here, L-strand replication will terminate when the nick on the H-strand is reached,
leading to a double stranded DNA (dsDNA) break near OriH (right middle panel).
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base excision repair and primer processing [57,59]. In addition to
full length FEN1, there have been reports of a shorter, mitochon-he  unstable single stranded region of the H-strand template is degraded (dotted
rey line and scissors, lower right panel), leaving a double stranded 11 kb linear
ragment.
uman RNase H1 open reading frame encodes a 286 residue long
rotein that contains a mitochondrial targeting sequence (MTS).
Nase H1 was ﬁrst cloned and puriﬁed in 1998 and shown to be
omologous to RNase HI from Escherichia coli [42,47,48]. Eukaryotic
Nases H1 have a conserved N-terminus for enhanced RNA/DNA
ybrid binding, a spacer region, and a conserved C-terminal cat-
lytic domain that is also essential for substrate binding.
.1.1. In vitro biochemical activity of RNase H1
Human RNase H1 was ﬁrst isolated from placenta and shown
o speciﬁcally cleave RNA hybridized to DNA [44]. Here we review
eatures of its activity that are relevant for primer removal (for a
ore detailed review, see [43]). RNase H1 cleaves endonucleolyti-
ally to generate 3′-OH and 5′-phosphate ends and requires at least
–4 ribonucleotides to be active [44,49].
The cleavage pattern of puriﬁed recombinant human RNase H1
as been studied using model RNA primer substrates comprised of
n RNA:DNA chimeric strand annealed to a DNA strand. Here, RNase
1 cleaves at numerous sites only between the ribonucleotides,
eaving behind 2 ribonucleotides attached to the 5′-end of the DNA
50]. These residual ribonucleotides would be incompatible with
igation [35]. An RNase H1 pathway in mitochondrial primer pro-
essing would therefore necessitate a second nuclease, analogous
o the nuclear RNase H2/FEN1 pathway.
Using long hybrids it has also been found that mammalian
Nases H1, unlike prokaryotic RNase HI, is a processive enzyme,
onferred by protein dimerization after substrate binding [51].
Nase H1 may  therefore have evolved to process long RNA/DNA
ybrids in higher organisms. This is signiﬁcant given that the RNA
rimer at OriH is ∼100 nt in length (Fig. 3B, upper panel). Repair 34 (2015) 28–38
5.1.2. Role of RNase H1 in mtDNA primer removal
An RNase H1 mouse knockout made over 10 years ago revealed
that RNase H1 has an essential, non-redundant function in mtDNA
replication [52]. Loss of RNase H1 in mice is embryonic lethal, with
embryos arresting development at E8.5 due to mtDNA depletion.
The timing corresponds to when the maternal mtDNA contribu-
tion becomes diluted and new mtDNA synthesis must begin as
cells start relying on the OXPHOS system for energy. While there
was a dramatic lack of mtDNA replication, it was not possible to
pinpoint at what step in replication the defect arises. Rather para-
doxically, RNases have also been hypothesized to cleave the RNA
transcript initiated by the transcription machinery at LSP to gen-
erate the mature 3′-primer end for replication initiation. RNase H
has been shown to be involved in primer formation in the bacterial
ColE1 plasmid [53], but if impaired primer maturation can explain
the lack of mtDNA replication in mammalian cells lacking RNase
H1 still needs clarifying.
To help resolve this issue, a study on cultured cells suggests that
RNase H1 is involved in primer removal rather than primer forma-
tion [37]. MtDNA replication was studied in cells after mtDNA was
transiently depleted with the use of the cytidine analogue dideoxy-
cytidine (ddC), an inhibitor of POL. When the drug is removed,
cells undergo intense mtDNA replication to repopulate the mtDNA
pool, providing an attractive system to study mtDNA replication.
While simple knockdown of core replication factors causes mtDNA
depletion, knockdown of accessory factors often requires the ddC
approach to elicit effects (for example [54]). Using this system com-
bined with siRNA mediated RNase H1 knockdown, it was found that
normal recovery of mtDNA levels required RNase H1 activity [37].
Furthermore, using 2D gel analysis to study replication inter-
mediates during the recovery phase, an increased number of
intermediates in the RNase H1-knockdown cells was observed.
These were more sensitive to S1 nuclease, indicating increased
mtDNA nicks and gaps. This phenotype is more consistent with
a defect in RNA primer removal after DNA replication, rather than
failure to initiate replication due to any lack of primer maturation. It
would be interesting to examine, using speciﬁc probes, whether the
nicks/gaps are enriched at the origins where RNA primers would be
expected to be located. For an overview of mtDNA defects associ-
ated with depletion of RNase H1, see Table 1.
5.2. FEN1
FEN1 is a structure speciﬁc 5′–3′ nuclease that cleaves sin-
gle stranded 5′-ﬂaps and also has weak exonuclease activity.
Human FEN1 is 380 amino acids in length and belongs to the
XPG/RAD2 family of endonucleases, the activity of which is con-
served from bacteria to mammals. FEN1 is a key factor in nuclear
DNA metabolism, including replication and repair, and has been
extensively studied and reviewed (for recent reviews, see [55,56]).
Biochemical and genetic studies, particularly in yeast, have unrav-
eled the role of FEN1 in Okazaki fragment maturation where it
operates in all three proposed pathways either alone, or in combi-
nation with RNase H2 or DNA2 (Fig. 4B). Since the initial isolation of
mammalian FEN1 homologs from nuclei in the late 1980s, it was  not
until 2008 that a possible role in mtDNA metabolism ﬁrst emerged.
FEN1 lacks a classical MTS  and although its mitochondrial local-
ization is contentious [57–60], FEN1 is implicated in mitochondrialdrial speciﬁc isoform [57,58]. Termed FENMIT, it is generated from
a downstream alternative translation initiation site [58]. FENMIT
lacks nuclease activity but binds preferentially to RNA ﬂaps, though
its physiological role in mitochondria remains unclear [58].
J.P. Uhler, M. Falkenberg / DNA Repair 34 (2015) 28–38 33
Table  1
Reported mtDNA defects and diseases associated with deﬁciency in RNase H1, FEN1, DNA2 and MGME1.
Sample source RNase H1 FEN1 DNA2 MGME1
Human patients No data No data Deletions [79] (Southern blot,
long PCR)
Depletion, deletions- incl. 11 kb
linear fragments, duplications,
increased 7S DNA [17,80]
(Southern blot, qPCR, long PCR)
Mitochondrial myopathy Multisystemic mt disease
Whole  body mouse KO MtDNA depletion [46] (qPCR) No data [66] No data [78] No data
Embryonic lethal (arrest E8.5) Embryonic lethal (arrest E4) Embryonic lethal (arrest before
E7.5)
SiRNA  in cultured cells Normal levels [35]
(qPCR)
Normal levels [35,54] (qPCR,
Southern blot)
Normal levels [35,54] (qPCR,
Southern blot, 2D-AGE)
Normal levels [54,80]
(Southern blot)
Normal number of
lesions [66] (long PCR)
Reduced replication
intermediates [73] (2D-AGE)
Increased replication
intermediates [80] (2D-AGE)
Transient increase in lesions
[67] (long PCR)
Increased 7S DNA [54,80]
(Southern blot)
Reduced repair of oxidative
damage [73] (long PCR)
SiRNA in transiently
mtDNA-depleted cells
No mtDNA recovery [35] (PCR) Normal replication
intermediates [35] (2D-AGE)
Normal replication
intermediates [35] (2D-AGE)
No data
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.2.1. In vitro biochemical activity of FEN1
Though its identity was not known at the time, FEN1 was  origi-
ally puriﬁed in the 1980s and 90s from a variety of cells and tissues
or its ability to cleave ﬂap substrates (for details see [61]). Since
hen, its biochemical activity and crystal structure on templates
ave been intricately studied [55,56]. FEN1 is a structure speciﬁc
uclease that preferentially recognizes and cleaves single stranded
′-ﬂaps (DNA or RNA) that are ﬂanked by dsDNA, substrates that
imic  primer ﬂap (or repair) intermediates.
FEN1 cleaves at the ﬂap base, releasing the intact ﬂap [55,56,62].
owever, longer ﬂaps that can be covered by the nuclear single
tranded DNA binding protein RPA are not ideal substrates for FEN1.
fﬁcient cleavage can be elicited by increased FEN1 concentrations,
r by the addition of DNA2 (discussed in Section 5.3). It has not how-
ver been tested whether the mitochondrial counterpart of RPA,
tSSB, has a similar inhibitory effect on FEN1 cleavage. Interest-
ngly, in a yeast reconstituted Pol DNA replication system, primer
aps coated with E. coli SSB, which is homologous to mtSSB, are
leaved as inefﬁciently as those covered with RPA [63].
.2.2. Role of FEN1 in mitochondrial primer removal
Loss of FEN1 in mice is embryonic lethal [64,65] causing defects
n nuclear DNA replication and cell proliferation [65]. Since these
mbryos die at a stage (∼E4) before they initiate mtDNA replication
rom the maternal pool, it was not possible to examine FEN1’s role
n mtDNA replication. Alternative approaches using siRNA medi-
ted FEN1 knockdown in cultured cells have also been used, with
one of these studies uncovering any effect on mtDNA (see Table 1).
ells with FEN1 knockdown showed no increases in single stranded
reaks [66], or abnormal mtDNA copy number [54]. Moreover,
nockdown of FEN1 (even in combination with DNA2) after tran-
ient mtDNA depletion did not result in slower repopulation, nor
ncreases in replication stalling or single stranded breaks/gaps [37].
In vitro approaches have been used to isolate ﬂap removal activ-
ty from mitochondrial extracts, with conﬂicting results regarding
EN1. While mitochondria do contain 5′-ﬂap removal activity, two
tudies excluded FEN1 [60,67] and two did not [57,59]. In the lat-
er studies, mitochondrial 5′-ﬂap endonuclease activity could be
bolished by FEN1 immunodepletion and restored by adding back
uriﬁed recombinant FEN1.
Another biochemical approach used an in vitro mtDNA replica-
ion system with mitochondrial extracts and a gapped substrate
ontaining a downstream 5′-ﬂap [59]. In such assays, the gap in theresis.
substrate is ﬁlled by DNA synthesis, creating a ligatable nick only
if the 5′-ﬂap is removed. DNA ligation was reduced or abolished
if FEN1 was immunodepleted from the mitochondrial extracts,
but could be restored by adding back puriﬁed recombinant FEN1
[59]. Similar results were also obtained using only puriﬁed pro-
teins (FEN1, POL, and Lig3) instead of extract. These assays relied
on preformed ﬂaps, so whether FEN1 together with POL strand
displacement synthesis is sufﬁcient to remove a fully annealed
RNA primer, as shown in a reconstituted nuclear system with Pol,
remains to be shown.
5.3. DNA2
DNA2 is a multifaceted DNA processing enzyme conserved
in eukaryotes that contains both nuclease and ATPase/helicase
domains. Human DNA2, a 1060 residue long protein, is a mem-
ber of the PD-(D/E)XK superfamily with homology to bacterial
RecB nuclease. Studies largely in yeast have shown its involve-
ment in nuclear DNA replication, repair and telomere replication.
Human DNA2 was not successfully puriﬁed until 2006, when two
groups showed it had similar activity to the yeast protein, possess-
ing 5′–3′ and 3′–5′ ssDNA endonuclease activity, ATPase activity,
but weak 5′–3′ helicase activity [68,69]. It also possesses single
strand annealing, strand exchange, and strand resection activities
[70,71]. DNA2, together with FEN1, is implicated in the long ﬂap
pathway of Okazaki maturation (Fig. 4B), and in mitochondrial
primer ﬂap removal and base excision repair [59]. DNA2 contains
a non-canonical internal MTS  and several approaches have shown
it localizes to mitochondria [59,72].
5.3.1. In vitro biochemical activity of DNA2
Until recently, due to difﬁculties in purifying human DNA2, the
vast majority of biochemical characterizations have been carried
out on yeast DNA2. Nonetheless, their activities appear to be quite
similar. When presented with model primer ﬂap substrates, human
DNA2 has been found to preferentially bind to and cleave longer
ﬂaps [74]. It cuts the ﬂaps at numerous positions, leaving behind a
short ﬂap that is resistant to DNA2 cleavage.
DNA2 cleaves substrates with 5′- or 3′-ﬂaps with equal efﬁ-
ciency [68,69], though it cleaves closer to the ﬂap base when
presented with a 5′-ﬂap [68]. Addition of RPA stimulates its 5′–3′
nuclease activity [68], thereby switching DNA2 into a 5′–3′ nuclease
optimized for primer removal [75]. No studies have addressed the
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In mitochondria, the primers at OriH and OriL differ substan-
tially both in length and genomic context (Fig. 3B), and we suggest4 J.P. Uhler, M. Falkenberg 
mpact of mtSSB, the mitochondrial counterpart of RPA, on DNA2
ctivity. The fact that yeast DNA2 can cleave yeast RPA coated ﬂaps,
ut not E. coli SSB coated ﬂaps [63], suggests that ﬂaps covered with
tSSB (homologous to E. coli SSB) might be DNA2-resistant. This
ould be consistent with the speciﬁc binding between DNA2 and
PA [63,76]. In terms of mitochondrial primer removal it will be
mportant to establish what effect mtSSB has on its activity.
.3.2. Role of DNA2 in mitochondrial primer removal
Whether DNA2 contributes to the cleavage of a gapped sub-
trate with a downstream 5′-ﬂap has been studied in mitochondrial
xtracts. Immunodepletion of DNA2 from these extracts reduced,
ut did not abolish, the production of ligatable ends [59]. Using only
uriﬁed proteins (POL, Lig3 and DNA2) no ligated products were
ormed, however, DNA2 did stimulate DNA ligation in the presence
f FEN1 [59]. These ﬁndings are consistent with previous studies
howing that DNA2 is unable to cleave short ﬂaps.
It has also been shown by co-immunoprecipitation and pull-
own assays that DNA2 interacts with POL [59]. This interaction
timulated POL DNA synthesis on double stranded circular DNA,
resumably via the DNA2 helicase domain [59]. In the presence
f DNA2, POL synthesized DNA up to 400 nt in length [59], well
bove the length of the primers at OriL or OriH. Thus, DNA2 may
elp to remove RNA primers either by cleaving pre-formed ﬂaps,
nd/or by facilitating RNA primer displacement and ﬂap formation
s POL completes DNA synthesis.
Knockout of DNA2 in mice is embryonic lethal, with develop-
ent arresting before E7.5 and the initiation of mtDNA replication,
recluding meaningful mtDNA analysis [77]. Recently, different
NA2 mutations in patients with muscle mitochondrial dysfunc-
ion were uncovered [78]. Southern blot and long PCR on mtDNA
rom patient muscle biopsies revealed multiple mtDNA deletions
78]. In vitro assays on the puriﬁed recombinant proteins showed
hat the mutant DNA2 proteins had reduced nuclease, ATPase,
nd/or abnormal helicase activity. However, whether DNA2 is
nvolved in primer removal at the origins, or has another function
n mitochondria such as in DNA repair, still needs to be determined.
There is little agreement concerning the effects on mtDNA after
iRNA mediated DNA2 knockdown in cultured cells (see Table 1
or an overview). One study observed no effect on mtDNA levels
easured by Southern blot [54], while another reported a mild
eduction based on replication intermediates in 2D gel analysis
72]. Using ddC induced transient mtDNA depletion, DNA2 knock-
own had no effect on mtDNA recovery or the abundance of single
tranded gaps and nicks, not even in combination with FEN1 deple-
ion [37]. On the other hand, DNA2 knockdown has been reported
o elicit increased mtDNA lesions and hamper DNA repair [66,72].
.4. MGME1
The identiﬁcation of MGME1, also known as Ddk1, was  ﬁrst
eported in 2013 by two different groups and was  shown to be
n exclusively mitochondrial protein [54,79]. It belongs to the
ecB subfamily of PD-(D/E)XK nucleases and contains a classical
TS. Mutations in the protein cause mitochondrial disease with
atients exhibiting a range of abnormal mtDNA phenotypes [79].
he human MGME1 protein has been characterized in vitro and
hown to be a DNA endo-/exonuclease with strong preference for
sDNA [54,79]. MGME1  is the least evolutionarily conserved of the
uclease candidates—orthologs are found only in Metazoa, Cap-
aspora and Monosiga, but not in some insects such as Drosophila
54]..4.1. In vitro biochemical activity of MGME1
Recombinant MGME1  has been expressed and puriﬁed from E.
oli and cultured human cells, and shown to have a strong prefer- Repair 34 (2015) 28–38
ence for cleaving single stranded over double stranded DNA [54,79].
It has no activity on RNA, nor when hybridized to DNA. Using sub-
strates that resemble primer ﬂap intermediates, it was shown that
MGME1  efﬁciently cleaves 5′-DNA ﬂaps [79]. Final cleavages cen-
ter at or near the ﬂap base [79]. Though MGME1  cannot cut RNA, it
can cut within the DNA of an RNA–DNA chimera, a few nucleotides
downstream of the RNA–DNA junction [54,79]. MGME1 ﬂap cleav-
age has only been tested on long ﬂaps (30 nt), and it would be worth
examining its activity on short ﬂaps.
Like FEN1 and DNA2, MGME1  absolutely requires a free end for
cleavage [79]. A preference for 5′-ﬂap versus 3′-ﬂap cleavage is sig-
niﬁcant for primer removal. Whether MGME1  has a preference is
not entirely clear. By comparing the cleavage pattern of 5′ and 3′-
ﬂap substrates, or using biotin-streptavidin blockage of either the
5′ or 3′-end of ssDNA, it was  concluded that MGME1  cleaves 5′-ends
more efﬁciently [79]. However, another study found that MGME1
had a 3′-end or no end preference, depending on the substrate used
[54]. It would be interesting to test whether a factor such as mtSSB
would shift MGME1’s polarity in the same way as RPA does for
DNA2.
5.4.2. Role of MGME1 in mitochondrial primer removal
Loss-of-function mutations in MGME1  can cause mitochondrial
disease in humans [20,79]. Analysis of mtDNA from patient muscle
biopsies or ﬁbroblast cells showed a spectrum of mtDNA defects,
including deletions, depletions, rearrangements, and 7S DNA accu-
mulation (Table 1). Patient ﬁbroblasts transiently exposed to ddC
in order to artiﬁcially deplete mtDNA showed greatly impaired
mtDNA repopulation. Knockdown of MGME1  using siRNA in nor-
mally growing HeLa cells did not yield any mtDNA loss [54,79], not
even in combination with FEN1 or DNA2 depletion [54]. 2D-AGE
analysis did however reveal increased levels of replication inter-
mediates, consistent with similar ﬁndings in patient ﬁbroblasts
[79].
MGME1  patient cells also contain an 11 kb truncated linear
mtDNA fragment, the ends of which map  near OriH and OriL [20].
The OriL end of the linear deletion maps precisely within the RNA
primer-DNA transition zone, while the more heterogeneous OriH
ends span largely within a 100 nt range between OriH and CSB2.
The fact that both MGME1-deﬁciency and POL exonuclease deﬁ-
ciency (mutator mice) give rise to a very similar subgenomic linear
fragment has valuable implications for how mtDNA is replicated
and primers are removed. Given the biochemical properties of
MGME1, it is conceivable that the fragment is generated due to
incomplete primer ﬂap processing at OriH (discussed in Section 7).
Furthermore, 7S DNA contains 5′ extended ends in MGME1  deﬁ-
cient patient cells. This suggests that 7S DNA is normally processed
to the mature form through single stranded ﬂap intermediates and
MGME1  cleavage [20].
Finally, reciprocal co-immunoprecipitation studies revealed
that MGME1  and POL interact [20]. Conceivably, a primer ﬂap pro-
cessing factor would physically interact with the DNA polymerase
in order to coordinate ﬂap cleavage and strand displacement syn-
thesis.
6. Models of mitochondrial primer removal pathwaysthat they are possibly removed by different mechanisms. Sufﬁcient
data in the disparate literature allows us to piece together three
speculative models on how primer processing might occur, using
Okazaki fragment maturation models as a framework (Fig. 6).
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.1. RNase H1 primer removal model
RNase H1 is an essential mtDNA replication protein that causes
tDNA defects that are consistent with a role in primer removal.
Nase H1 can efﬁciently process RNA primers, but it cannot remove
he last two ribonucleotides of an RNA–DNA chimera. Based on
he limited strand displacement activity of POL we  propose that
nce POL reaches the 5′-end of the remaining di-ribonucleotide
rimer, the polymerase creates short ﬂaps. These short 5′-ﬂaps
an then be cleaved away by a single stranded nuclease, such as
EN1. MGME1  could potentially also cleave away the remaining di-
ibonucleotide primer ﬂap, but MGME1  short ﬂap cleavage remains
o be tested and would require the ﬂap to include downstream DNA
ince MGME1  is unable to cut RNA.
.2. Short ﬂap model
In the absence of RNase H1 activity, RNA primers would need to
e displaced into ﬂaps for nucleolytic cleavage. A short ﬂap model
ould operate at OriL, where the primer is only ∼25 nt long, but
ould seem inefﬁcient at OriH where the primer is much longer.
f all the candidate nucleases, FEN1 is the only one that can cleave
NA ﬂaps. POL together with FEN1 could conceivably engage in
oordinated nick translation to remove the annealed RNA primer,
s shown for Pol and FEN1, but this possibility needs to be exper-
mentally addressed in vitro.
.3. Long ﬂap model
DNA2 in combination with FEN1 has been shown to be able to
rocess longer ﬂaps (20 nt) in an in vitro mtDNA replication sys-
em [59]. Also, MGME1  can cleave long ﬂaps (30 nt) in nuclease
ssays [79]. Some questions remain however, for example, what
ffect does mtSSB binding to very long ﬂaps have on DNA2, FEN1
nd MGME1, and what creates the long ﬂaps in the ﬁrst place? What
s clear from in vitro data is that the strand displacement activity of
OL is insufﬁcient. However, DNA2 can stimulate POL DNA syn-
hesis on duplex DNA [59] and the yeast protein has been shown
o unwind DNA/RNA hybrids [76]. Other helicases, the formation of
econdary DNA structures, or pre-terminated transcription, could
onceivably also facilitate long ﬂap formation (see Section 7).
. OriH primer processing and implications for replication
nitiation
Processing of the unusually long OriH primer in the complex
enomic context of the NCR presents interesting problems as well
s informative implications. Due to its considerable length of 100 nt,
e favor RNA primer removal via an effective pathway such as
Nase H1 degradation over a short ﬂap pathway that could entail up
o ∼100 cycles of POL-dependent ﬂap formation and nucleolytic
leavage.
An unresolved peculiarity in mtDNA initiation is that the
NA–DNA transitions map  just after CSB2, yet the 5′-ends of
ascent DNA map  ∼100 nt downstream of CSB2, at OriH (Fig. 3B).
t is not typically possible to distinguish between the 5′-ends of
arious nascent H-strands (pre-terminated 7S DNA or full-length
roducts), but it is generally accepted that the positions of the
′-ends are shared [14,15]. Regardless, the discrepancy between
NA–RNA transitions and OriH implies that the nascent H-strand
ndergoes considerable 5′-end processing which remains an unre-
olved enigma.We propose that the RNA primer between LSP and CSB2 is ﬁrstly
emoved by RNase H1 shortly after replication initiation (Fig. 7A).
he remaining ∼100 nt of DNA between CSB2 and OriH are then
emoved by a ﬂap pathway. Evidence for a ﬂap pathway comes Repair 34 (2015) 28–38 35
from patients who  are deﬁcient in MGME1  where the 5′-ends of
the nascent strands are extended towards the CSB regions [20].
What creates the ﬂaps between CSB2 and OriH is unclear, but a
long-ﬂap pathway might involve a helicase, POLRMT, or secondary
structures (Fig. 7A). One of the several reported mitochondrial
helicases may  fulﬁll this role, however, the replicative helicase
TWINKLE is unlikely to be involved since TWINKLE itself requires a
ﬂap to be active [80,81]. In support of POLRMT, a highly abundant
polyadenylated transcript known as 7S RNA is initiated from LSP
and its 3′-end maps at CSB1, just upstream of OriH (see Fig. 1 for
positions) [82,83]. Finally, several predicted secondary DNA struc-
tures in the L-strand of the D-Loop have been reported, which could
cause displacement of the nascent strand into a ﬂap [84,85].
Meticulous mapping of the 11 kb linear fragment that is found
both in mutator mice and MGME1  patients is very revealing [20,28].
In a model proposed by us, the linear fragment is an abnormal
replication product that arises due to failed ligation of the nascent
H-strand at OriH (see Fig. 5) [34]. Undesirable creation of ﬂaps
by exonuclease-deﬁcient POL in the mutator mice or failure to
remove ﬂaps by MGME1  in the patients, will lead to ligation fail-
ure and a nick around OriH. When this nicked mtDNA molecule is
replicated, initiation of H-strand synthesis is not disturbed because
the L-strand is intact (Fig. 5, left panels). However, when replica-
tion from OriL initiates on the nicked H-strand, the nascent L-strand
will terminate at the nick, generating a double stranded break near
OriH (Fig. 5, right panels).
In mutator mice, one end of the linear fragment maps down-
stream of OriH (in a ∼600 nt range between OriH and TAS) [28], but
in MGME1  patients, the equivalent end maps mainly upstream of
OriH (in a ∼100 nt region between CSB2 and OriH) [20] (Fig. 7B).
This difference can be explained by the above model: MGME1  deﬁ-
ciency leads to failed 5′-end processing of the nascent H-strand
upstream of OriH, while in mutator mice, excessive strand displace-
ment synthesis by exonuclease-deﬁcient POL shifts the 5′-end
downstream of OriH.
Nucleases other than MGME1, such as FEN1, also play a likely
role in 5′-end processing since MGME1  is not essential and the 11 kb
fragment is much less abundant in MGME1  patients than in mutator
mice, suggesting that the ligation failure is not complete.
Regardless of the mechanism, what is the purpose of shifting the
5′-end of the nascent DNA from the RNA–DNA transition point at
CSB2 to OriH? We  speculate that it may  be to facilitate ligation of
the newly replicated DNA. The NCR is a complex region with many
regulatory sequences and activities, particularly between LSP and
CSB1. By moving the delicate and essential step of ligation away
from this area, interference can be minimized. How 5′-end process-
ing terminates speciﬁcally at OriH remains an unsolved question.
Our understanding of primer processing is in its infancy, and more
studies on how primers are processed will inevitably also shed
more light on the initiation of mtDNA replication.
8. Concluding remarks
There has been a boom in the mtDNA replication ﬁeld during
recent decades, stimulated by the realization that mtDNA defects
underlie numerous diseases and can be linked to biological ageing.
However, with the focus on initiation and elongation, few stud-
ies have yet speciﬁcally addressed the issue of primer removal.
Currently, there are virtually no studies that have reconstituted
mtDNA replication, primer removal and ligation in the test tube.
These types of assays have contributed immensely to the ﬁeld of
Okazaki fragment maturation. Moreover, mtDNA defects that are
relevant to primer removal are typically overlooked and difﬁcult to
predict.
36 J.P. Uhler, M. Falkenberg / DNA Repair 34 (2015) 28–38
Fig. 6. Models of mitochondrial primer removal.
RNase H1 pathway—RNase H1 degrades most of the primer (red wavy line), the remaining ribonucleotides are displaced into a short ﬂap by POL and then cleaved by FEN1,
or  possibly MGME1  in which case the ﬂap must also contain DNA. Short ﬂap pathway—short RNA ﬂaps created by POL strand displacement synthesis are cleaved by FEN1
through reiterative cycles. Long ﬂap pathway—a long RNA:DNA ﬂap is formed and covered by mtSSB. DNA2, MGME1 or FEN1 are possible nuclease candidates. Any remaining
short  ﬂap is cleaved by FEN1, or possibly MGME1. Black lines: DNA; red wavy lines: RNA primer. See text in Section 6 for further details.
Fig. 7. Primer removal and 5′-end processing at OriH.
(A) Model on how the mature 5′-end of the nascent H-strand is shifted to OriH. RNase H1 removes the RNA primer (red wavy line), leaving behind 1–2 ribonucleotides
attached to the 5′-end of the nascent H-strand (blue line). The dashed blue line represents the region of DNA that is then removed, possibly by three alternative long-ﬂap
pathways: (i) POLRMT transcription from LSP terminates near OriH; (ii) a 5′–3′ helicase unwinds the DNA; (iii) secondary structures form in the template strand. (B) Mapping
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if  the OriH ends of the linear 11-kb mtDNA fragment found in MGME1  patient cells a
atients this is between CSB2 and OriH, in mutator mice the range is between Or
ertical  line.
What seems likely is that primer removal involves several
actors and pathways. The in vivo evidence combined with their bio-
hemical activity make RNase H1 and MGME1  two of the strongest
andidates. Although there is good in vitro evidence for FEN1’s role,
here are no clear effects on mtDNA when it is depleted and there is
isagreement about its mitochondrial localization. It may  however
e a question of time before more evidence emerges. It was  not long
go for example, that DNA2 was accepted to be mitochondrial and
utations in patients with mitochondrial disease were mapped to
NA2. Due to the essential nuclear function of DNA2 and FEN1, it
ould be worth investigating the design of new knockout models
o speciﬁcally address the mitochondrial function of these proteins.
lso when analyzing mtDNA, more discerning tools would be valu-
ble to better distinguish between replication and repair defects, as
t is not clear to what extent DNA2, FEN1 and MGME1  are involved
n either. Many other questions remain, for example, what effectutator mice. Dashed lines represent the range in which ends were found: in MGME1
 TAS. The classical 5′-end (OriH) of the nascent H-strand is indicated with a grey
does mtSSB have on the activity of these proteins? Moreover, in
Okazaki fragment maturation the DNA clamp and processivity fac-
tor, PCNA (proliferating-cell nuclear antigen), serves as a platform
to direct nuclease and ligase activities [86]. What, if any, factor coor-
dinates these activities in mitochondria, which lack PCNA, remains
to be established.
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